Abstract
A double-blind parallel multi-centre study of 102 patients with rheumatoid arthritis (RA) was performed, comparing ibuprofen (1200-2400 mg daily) and ketoprofen (150-300 mg daily) a new non-steroidal, anti-inflammatory agent, over a three month period. Ketoprofen was well tolerated and shown to have comparable efficacy with ibuprofen. Longterm efficacy and tolerance studies are indicated.
Original language | English (US) |
---|---|
Pages (from-to) | 153-157 |
Number of pages | 5 |
Journal | Journal of Rheumatology |
Volume | 4 |
Issue number | 2 |
State | Published - Jun 1977 |
Externally published | Yes |
ASJC Scopus subject areas
- Rheumatology
- Immunology and Allergy
- Immunology